A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...

A set of breakthroughs from scientists at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) is ...

In this interview, Professor James J. Collins, founder of the field of Synthetic Biology, discusses his journey to founding ...

This sale includes real estate, intellectual property and machinery and equipment, representing a rare opportunity to acquire ...

The Revolver program in development by the Office of Naval Research (ONR) is rapidly moving forward into the fleet to provide ...

A 2013 nobel prize laureate has joined a molecular diagnostic company’s board of directors. Meanwhile, the American ...

At ETH Zurich, scientists from many different fields are working on something that seems straight out of science fiction.

Tiny sensors, similar to breathalyzers, could "sniff out" bacterial infections and detect antimicrobial-resistant bacteria in ...

Researchers are developing a living material that actively extracts carbon dioxide from the atmosphere. Photosynthetic cyanobacteria grow inside it, forming biomass and solid minerals and thus binding ...

Microglia are a specialized type of immune cell that accounts for about 10% of all cells within the brain and spinal cord. They function by eliminating infectious microbes, dead cells, and ...

In this work, we successfully developed a novel, compact, and disposable fully 3D-printed electrochemical cell incorporated into the rear side of a medical scalpel, named Lab-on-a-Scalpel.

Synthetic Design Lab, a next-generation antibody-drug conjugate (ADC) company advancing its novel SYNTHBODY therapeutic platform against a range of cancer indications, emerged from stealth today ...